Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia

被引：0
|
作者：
Nakajima, Asuka [1 ,2 ]
Iwamuro, Hirokazu [3 ]
Tokugawa, Joji [4 ]
Odo, Masahiko [5 ]
Shimo, Yasushi [1 ,2 ]
机构：
[1] Juntendo Univ Nerima Hosp, Dept Neurol, Tokyo, Japan
[2] Juntendo Univ, Sch Med, Dept Res & Therapeut Movement Disorders, Tokyo, Japan
[3] Juntendo Univ, Sch Med, Dept Neurosurg, Tokyo, Japan
[4] Juntendo Univ Nerima Hosp, Dept Neurosurg, Tokyo, Japan
[5] Juntendo Univ Nerima Hosp, Dept Anesthesia & Pain Med, Tokyo, Japan
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2023年 / 50卷 / 02期
基金：
日本学术振兴会;
关键词：
Dyskinesia; Propofol; Parkinson's disease; Deep brain stimulation; Cortico-basal ganglia circuits; DOPAMINE TURNOVER;
D O I：
10.1017/cjn.2022.4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：322 / 323
页数：2
相关论文
共 50 条
  • [41] Investigation of PRKN Mutations in Levodopa-Induced Dyskinesia in Parkinson's Disease Treatment
    Bispo, Ana Gabrielle
    Silva, Caio S.
    Sena-dos-Santos, Camille
    Moura, Dafne Dalledone
    Koshimoto, Brenda Hanae Bentes
    Santos-Lobato, Bruno Lopes
    Ribeiro-dos-Santos, Andrea
    Cavalcante, Giovanna C.
    BIOMEDICINES, 2023, 11 (08)
  • [42] Prominent Oromandibular Dystonia as Levodopa-induced Dyskinesia in Idiopathic Parkinson's Disease
    Tee, Tze Yuan
    Khoo, Ching Soong
    Norlinah, Mohamed Ibrahim
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2019, 6 (04): : 330 - 331
  • [43] Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson's Disease
    Song, Tianbin
    Li, Jiping
    Mei, Shanshan
    Jia, Xiaofei
    Yang, Hongwei
    Ye, Yongquan
    Yuan, Jianmin
    Zhang, Yuqing
    Lu, Jie
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [44] Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Schaeffer, Eva
    Pilotto, Andrea
    Berg, Daniela
    CNS DRUGS, 2014, 28 (12) : 1155 - 1184
  • [45] Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease
    Fraix, V
    Pollak, P
    Van Blercom, N
    Xie, J
    Krack, P
    Koudsie, A
    Benabid, AL
    NEUROLOGY, 2001, 57 (10) : S60 - S62
  • [46] Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson's disease
    Ivanova, S. A.
    Alifirova, V. M.
    Freidin, M. B.
    Pozhidaev, I. V.
    Fedorenko, O. Y.
    Bokhan, N. A.
    Zhukova, I. A.
    Zhukova, N. G.
    Wilffert, B.
    Loonen, A. J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1039 - S1040
  • [47] White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease
    Chung, Seok Jong
    Yoo, Han Soo
    Lee, Yang Hyun
    Jung, Jin Ho
    Baik, KyoungWon
    Ye, Byoung Seok
    Sohn, Young H.
    Lee, Phil Hyu
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (02): : 229 - 238
  • [48] Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
    Kobylecki, Christopher
    Burn, David J.
    Kass-Iliyya, Lewis
    Kellett, Mark W.
    Crossman, Alan R.
    Silverdale, Monty A.
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 452 - 455
  • [49] Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: Opportunities for novel treatments
    Bezard, Erwan
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 535 - 535
  • [50] Risk factors for levodopa-induced dyskinesia in Serbian Parkinson's disease patients
    Markovic, V.
    Djuric, G.
    Pekmezovic, T.
    Kostic, V.
    Svetel, M.
    MOVEMENT DISORDERS, 2013, 28 : S317 - S317
12345